Financial intelligence for Asia's healthcare markets
 
 
Remember me:


News articles    

JCG Investment Holdings to acquire 51% of the shares in Beverley Wilshire Medical Centre, a Malaysia-based medical aesthetics group, in a deal thought to be worth between S$4.6 million and S$5 million.
China will encourage more qualified physicians to run their own clinics, either working full time or part time, according to a guideline jointly issued by the country’s five authorities.
The Chinese government spent more than ¥1.5 trillion (about £222 billion) on its healthcare sector last year, an ¥84 billion increase on 2017, the state council has reported.
Morgan Stanley India Infrastructure is investing 145 crore rupees ($21.1 million) in HealthMaP Diagnostics, the diagnostics imaging unit of Manipal Health Enterprise.
Shenzhen-based BGI Genomics and digital health start-up, Pryzm Health based in Southport, Queensland have signed a memorandum of understanding for collaboration to advance precision public health in Australia.
Melbourne-based BTC health has announced that its subsidiary, BTC Speciality Health has partnered with Admedus to acquire part of its hospital infusion business for A$6.3 million.
Chinese e-commerce company JD.com is raising over $1 billion for its healthcare subsidiary JD Health from investors including CPEChina Fund, CICC Capital and Baring Private Equity Asia.
Singapore-based Nuffield Dental Holdings has signed a S$2.25 million ($1.69 million) redeemable convertible loan agreement (RCL) with Zenmedic Capital.
CapBuild Clinical Skills, a healthcare analytics start-up, has raised an undisclosed amount of funding from early stage venture capital and health sector accelerator, HealthStart India.
Australian medication platform MedAdvisor and Singapore-based healthcare service provider Zuellig Pharma have formed a joint venture in Singapore.
12345678910...

Subscribe to our news RSS feed Get the RSS for HealthInvestor Asia



Civica

AON


Markets

The IPO market in Hong Kong is hotting up again and it looks as though 2019 is going to be as busy with biotech company floats as last year was.


Podcasts

Analysis

HealthInvestor Asia twitter feed



Podcasts

HealthInvestor UK